L’ovaire de l’insulinorésistance

Gynecologie Obstetrique Fertilite

Volumn 29, Issue 10, 2001, Pages 680-691

  Belaisch, J ^a   Allart, J P ^a   Nahmanovici, C ^a  

^a NONE   (France)

Author keywords

Anovulation; Hyperandrogenism; Insulin resistance; Laparoscopy; Polycystic ovarian syndrome

Indexed keywords

ANDROGEN; INSULIN; METFORMIN;

ANDROGEN SYNTHESIS; ANOVULATION; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; HYPERANDROGENISM; INFERTILITY THERAPY; INSULIN RESISTANCE; LAPAROSCOPY; OVARY CANCER; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; REVIEW; SYNDROME X;

EID: 0035170249     PISSN: 12979589     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-9589(01)00211-9     Document Type: Short Survey

References (61)

1. Le virilisme pilaire et son association à l'insuffisance glycolytique (diabète des femmes à barbe
2. Acanthosis nigricans: A study of 90 cases
3. The syndromes of insulin resistance and acanthosis nigricans
4. Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome
5. Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor
6. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease
7. Hyperinsulinemia in hyperthecosis of the ovaries
8. Hyperinsulinemic hyperandrogenism
9. Insulin resistance in non-obese patients with polycystic ovarian disease
10. A contemporary overview
11. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism
12. Clinical, biochemical and ovarian morphologic features in women acanthosis nigricans and masculinization
13. Hyperinsulinisme et hyperandrogenie
14. Specific binding sites for insulin-like growth factor I in the ovarian stroma of women with polycystic ovarian disease and stromal hyperthecosis
15. Expression of insulin-receptor substrate 1 and 2 in ovaries from women with insulin resistance and from controls
16. A direct effect of hyperinsulinemia on serum sex-hormone binding globulin levels in obese women with the polycystic ovary syndrome
17. A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with the polycystic ovary syndrome
18. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: Relevance to mechanism of anovulation
19. Thirty-seven candidate genes for PCOS: Strongest evidence for linkage with follistatin
20. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
21. Serum vascular endothelial growth factor and doppler blood flow velocities in in vitro fertilization: Relevance to ovarian hyperstimulation syndrome and polycystic ovaries
22. Effects of laparoscopic ovarian drilling on serum vascular endothelial growth factor and on insulin responses to the oral glucose tolerance test in women with polycystic ovary syndrome
23. Role of vascular endothelial growth factor in ovarian physiology and pathology
24. Hyperandrogenic anovulation (the polycystic ovary syndrome) back to the ovary ?
25. Utero-ovarian arterial blood flow and hormonal profile in patients with polycystic ovary syndrome
26. The role of three dimensional ultrasonographic images in ovarian measurement
27. Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: Visual analysis versus computerized quantification
28. Transvaginal color doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease
29. Relationship of ovarian stromal volume to serum androgen concentrations in patients with polycystic ovary syndrome
30. Le sompk de l'adolescente: Où commence le pathologique, où finit le physiologique?
31. Puberty and polycystic ovarian syndrome: The insulin/insulin-like growth factor I hypothesis
32. Obesity, acanthosis nigricans, insulin resistance, and hyperandrogenemia: Pediatric perspective and natural history
33. Premature pubarche, ovarian hyperandrogenim, hyperinsulinism and the polycystic ovary syndrome: From a complex constellation to a simple sequence of prenatal onset
34. Inhibition of karyolysis but not karyorhexis in rat embryos exposed to high glucose
35. Ovocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients
36. Polycystic ovaries in pre and post menopausal women
37. Ovarian hyperthecosis, diabetes and hirsuties in post-menopausal women
38. Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovarysyndrome?
39. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: A retrospective cohort study
40. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role o fandrogens and progesterone
41. Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States)
42. Polycystic ovarian disease treated by electrocautery through the laparoscope
43. 3d Laparoscopic electrosurgical furrowing technique for the treatment of polycystic ovaries
44. Treatment of polycystic ovary disease with laparoscopic low-watt bipolar electroagulation of the ovaries
45. Les techniques endoscopiques de traitement des stérilités en relation avec un syndrome des ovaires micropolykystiques
46. Reproductive performance and three dimensional ultrasound volume determination of polycystic ovaries following laparoscopic ovarian drilling International
47. Sclérose corticale ovarienne. Considérations étiologiques
48. The use of laparoscopic ovarian electrocautery in preventing cancellation of in vitro fertilization cycles due to risk of ovarian hyperstimulation syndrome in women with polycystic ovaries
49. Hormonal changes in patients with polycystic ovarian disease after ovarian electrocautery or pituitary desensitization
50. The effect of laparoscopic multiple punch resection of the ovary on hypothalamic-pituitary axis in polycystic ovary syndrome
51. Mid follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: A possible mechanism regulating emergence of the dominant follicle
52. Surgically induced ovulation in the polycystic ovary syndrome: Wedge resection revisited in the age of laparoscopy
53. Résultats histologiques, biochimiques et therapeutiques obtenus chez les femmes dont les ovaires avaient été diagnostiqués Stein-Leventhal à la cœlioscopie
54. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone
55. Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors
56. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: A pilot study